Comparison of two fast physical measurements for the dose control of cytotoxic injectable preparations before administration. Application to 5- fluorouracile;Comparaison de deux mesures physiques rapides pour le controle de la dose des preparations injectables de medicaments anticancereux avant administration: Application au 5-fluorouracile

Journal de Pharmacie Clinique

Volumn 19, Issue 1, 2000, Pages 5-8

  Basuyau, F ^a   Brunelle, P ^a  

^a CENTRE HENRI BECQUEREL   (France)

Author keywords

Centralized preparation; Cytotoxic; Hospital pharmacy; Quick control; UV spectrophotometry; Weighing

Indexed keywords

FLUOROURACIL;

ACCURACY; ARTICLE; COMPUTER; DRUG IDENTIFICATION; DRUG MIXTURE; HOSPITAL PHARMACY; SPECTROPHOTOMETER; ULTRAVIOLET SPECTROPHOTOMETRY; WEIGHT;

EID: 0034040385     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chatelut E, Canal P, Brunner V, Chevreau C, Pujol A, Boneu A, Roche H, Houin G, Bugat R. Prediction of carboplatin clearance from standard morphological and biological patient characteristics. J Natl Cancer Inst 1995; 87: 573-80.
2. Chekharina EA. Errors in the drug therapy of malignant tumors. Med Sestra 1982; 41: 25-7.
3. Desoize B. To which criterion should the dosage of anticancer drug be adapted? Bull Cancer 1993; 80: 376-90.
4. Fernandez MN, Cabrera R, Sanjuan I, Barbolla L, Zaballa P. Hypertension, grand mal epilepsy, intestinal dyskinesia, sensitive motor neuropathy and hyponatemia resulting from acute vincristine overdosage. Sangre (Barc) 1981; 26: 209-15.
5. Fraterrigo CC, Jorgenson JA. Accuracy and efficiency of three methods of preparing piggyback admixtures. Am J Hosp Pharm 1982; 39: 1920-3.
6. Girard F, Menat C, Guenfoudi MP, Picot V, Aujoulat O, Drouhin JP, Vieille-Cessay G, Stoeckel C. Précision des préparations à base de cytostatiques : étude réalisée sur trois unités centralisées de reconstitution. J Pharm Clin 1999; 18: 62-3.
7. Hachimi-Idrissi S, Schots R, DeWolf D, Van Belle SJ, Otten J. Reversible cardiopathy after accident overdose of mitoxantrone. Pediatr Hematol Oncol 1993; 10: 35-40.
8. Henderson IC, Hayes DF, Gelman R. Dose response in the treatment of breast cancer : a critical review. J Clin Oncol 1988; 6: 1501-5.
9. Kurmar MA, Nayak R. A spectrophotometric method for detection of 5-Fluorouracil in plasma. Biochem Biophys Res Com 1990; 169: 1153-7.
10. Paule B, Brion N. Anticancer chemotherapy. Prevention of complications. Press Med 1998; 27: 2113-9.
11. Pharmacopée européenne, 30 édition, 1998: 16.
12. Rustum AB, Hoffman NE. Determination of 5-Fluorouracil in plasma and whole blood by ion-pair high-performance liquid chromatography. J Chromatogr 1998; 426: 121-8.
13. Samson MK, Rivkin SE, Jones SE, et al. Dose response and dose survival advantage for high versus low-dose cisplatin combined with vinblastin and bleomycin in disseminated testicular cancer. Cancer 1984; 53: 1029-35.
14. Van Warmerdam U. Tailor-made chemotherapy for cancer patients. Neth J Med 1997; 51: 30-5.
15. Walter AW. Errors involving pediatric patients receiving chemotherapy : a literature review. Med Pediatr Oncol 1997; 29: 155-6.
16. Zaniboni A, Simoncini E, Marpicati P, Montini E, Marini G. Severe delayed neurotoxicity after accidental high dose nitrogenn mustard. Am J Hematol 1988; 27: 305.